Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Next Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Leveraging Patient Advocacy To Scale Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources
Opening Keynotes, • 9/25/25 Opening Keynote: The Future of Rare Disease Trials Next Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Leveraging Patient Advocacy To Scale Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources
